The Experts below are selected from a list of 24 Experts worldwide ranked by ideXlab platform
V M Jackson - One of the best experts on this subject based on the ideXlab platform.
-
pharmacological profiling of neuropeptides on rabbit Vaginal wall and Vaginal Artery smooth muscle in vitro
British Journal of Pharmacology, 2009Co-Authors: K L Aughton, K Hamiltonsmith, J Gupta, J S Morton, Christopher Peter Wayman, V M JacksonAbstract:Background and purpose: Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in peripheral arousal has been ignored. Vascular and non-vascular smooth muscle relaxation in the vagina is important for female sexual arousal. To date, in vitro studies have focused on Vaginal strips with no studies on Vaginal arteries. The aim of this study was to compare the effects of sexual hypothalamic neuropeptides on rabbit Vaginal wall strips and arteries. Experimental approach: Tissue bath and wire myography techniques were used to measure isometric tension from strips and arteries, respectively. Key results: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) relaxed both preparations, effects that were only antagonized by the VIP/PACAP antagonist VIP6–28 (10 nM) and the PAC1 antagonist PACAP 6–38 (1 μM). The melanocortin agonist α-melanocortin-stimulating hormone (1 μM), but not bremelanotide (1 μM), also relaxed both preparations. Oxytocin and vasopressin contracted Vaginal preparations, which could be antagonized by the V1A antagonist SR 49059. Neuropeptide Y (NPY) and the NPY Y1 agonist Leu31, Pro34 NPY only contracted arteries, which was antagonized by the NPY Y1 receptor antagonist BIBP 3226. Melanin-concentrating hormone (MCH; 1 μM) contracted arteries. Conclusion and implications: Hypothalamic neuropeptides can exert contractile and relaxant effects on Vaginal strips and arteries. NPY Y1, V1A, MCH1 antagonists as well as VIP/PAC1 agonists may have therapeutic potential in both central and peripheral female sexual arousal. Differences in effect of neuropeptides between preparations raise the question of which preparation is important for female sexual arousal. British Journal of Pharmacology (2008) 155, 236–243; doi:10.1038/bjp.2008.253; published online 30 June 2008
K L Aughton - One of the best experts on this subject based on the ideXlab platform.
-
pharmacological profiling of neuropeptides on rabbit Vaginal wall and Vaginal Artery smooth muscle in vitro
British Journal of Pharmacology, 2009Co-Authors: K L Aughton, K Hamiltonsmith, J Gupta, J S Morton, Christopher Peter Wayman, V M JacksonAbstract:Background and purpose: Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in peripheral arousal has been ignored. Vascular and non-vascular smooth muscle relaxation in the vagina is important for female sexual arousal. To date, in vitro studies have focused on Vaginal strips with no studies on Vaginal arteries. The aim of this study was to compare the effects of sexual hypothalamic neuropeptides on rabbit Vaginal wall strips and arteries. Experimental approach: Tissue bath and wire myography techniques were used to measure isometric tension from strips and arteries, respectively. Key results: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) relaxed both preparations, effects that were only antagonized by the VIP/PACAP antagonist VIP6–28 (10 nM) and the PAC1 antagonist PACAP 6–38 (1 μM). The melanocortin agonist α-melanocortin-stimulating hormone (1 μM), but not bremelanotide (1 μM), also relaxed both preparations. Oxytocin and vasopressin contracted Vaginal preparations, which could be antagonized by the V1A antagonist SR 49059. Neuropeptide Y (NPY) and the NPY Y1 agonist Leu31, Pro34 NPY only contracted arteries, which was antagonized by the NPY Y1 receptor antagonist BIBP 3226. Melanin-concentrating hormone (MCH; 1 μM) contracted arteries. Conclusion and implications: Hypothalamic neuropeptides can exert contractile and relaxant effects on Vaginal strips and arteries. NPY Y1, V1A, MCH1 antagonists as well as VIP/PAC1 agonists may have therapeutic potential in both central and peripheral female sexual arousal. Differences in effect of neuropeptides between preparations raise the question of which preparation is important for female sexual arousal. British Journal of Pharmacology (2008) 155, 236–243; doi:10.1038/bjp.2008.253; published online 30 June 2008
J S Morton - One of the best experts on this subject based on the ideXlab platform.
-
pharmacological profiling of neuropeptides on rabbit Vaginal wall and Vaginal Artery smooth muscle in vitro
British Journal of Pharmacology, 2009Co-Authors: K L Aughton, K Hamiltonsmith, J Gupta, J S Morton, Christopher Peter Wayman, V M JacksonAbstract:Background and purpose: Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in peripheral arousal has been ignored. Vascular and non-vascular smooth muscle relaxation in the vagina is important for female sexual arousal. To date, in vitro studies have focused on Vaginal strips with no studies on Vaginal arteries. The aim of this study was to compare the effects of sexual hypothalamic neuropeptides on rabbit Vaginal wall strips and arteries. Experimental approach: Tissue bath and wire myography techniques were used to measure isometric tension from strips and arteries, respectively. Key results: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) relaxed both preparations, effects that were only antagonized by the VIP/PACAP antagonist VIP6–28 (10 nM) and the PAC1 antagonist PACAP 6–38 (1 μM). The melanocortin agonist α-melanocortin-stimulating hormone (1 μM), but not bremelanotide (1 μM), also relaxed both preparations. Oxytocin and vasopressin contracted Vaginal preparations, which could be antagonized by the V1A antagonist SR 49059. Neuropeptide Y (NPY) and the NPY Y1 agonist Leu31, Pro34 NPY only contracted arteries, which was antagonized by the NPY Y1 receptor antagonist BIBP 3226. Melanin-concentrating hormone (MCH; 1 μM) contracted arteries. Conclusion and implications: Hypothalamic neuropeptides can exert contractile and relaxant effects on Vaginal strips and arteries. NPY Y1, V1A, MCH1 antagonists as well as VIP/PAC1 agonists may have therapeutic potential in both central and peripheral female sexual arousal. Differences in effect of neuropeptides between preparations raise the question of which preparation is important for female sexual arousal. British Journal of Pharmacology (2008) 155, 236–243; doi:10.1038/bjp.2008.253; published online 30 June 2008
Christopher Peter Wayman - One of the best experts on this subject based on the ideXlab platform.
-
pharmacological profiling of neuropeptides on rabbit Vaginal wall and Vaginal Artery smooth muscle in vitro
British Journal of Pharmacology, 2009Co-Authors: K L Aughton, K Hamiltonsmith, J Gupta, J S Morton, Christopher Peter Wayman, V M JacksonAbstract:Background and purpose: Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in peripheral arousal has been ignored. Vascular and non-vascular smooth muscle relaxation in the vagina is important for female sexual arousal. To date, in vitro studies have focused on Vaginal strips with no studies on Vaginal arteries. The aim of this study was to compare the effects of sexual hypothalamic neuropeptides on rabbit Vaginal wall strips and arteries. Experimental approach: Tissue bath and wire myography techniques were used to measure isometric tension from strips and arteries, respectively. Key results: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) relaxed both preparations, effects that were only antagonized by the VIP/PACAP antagonist VIP6–28 (10 nM) and the PAC1 antagonist PACAP 6–38 (1 μM). The melanocortin agonist α-melanocortin-stimulating hormone (1 μM), but not bremelanotide (1 μM), also relaxed both preparations. Oxytocin and vasopressin contracted Vaginal preparations, which could be antagonized by the V1A antagonist SR 49059. Neuropeptide Y (NPY) and the NPY Y1 agonist Leu31, Pro34 NPY only contracted arteries, which was antagonized by the NPY Y1 receptor antagonist BIBP 3226. Melanin-concentrating hormone (MCH; 1 μM) contracted arteries. Conclusion and implications: Hypothalamic neuropeptides can exert contractile and relaxant effects on Vaginal strips and arteries. NPY Y1, V1A, MCH1 antagonists as well as VIP/PAC1 agonists may have therapeutic potential in both central and peripheral female sexual arousal. Differences in effect of neuropeptides between preparations raise the question of which preparation is important for female sexual arousal. British Journal of Pharmacology (2008) 155, 236–243; doi:10.1038/bjp.2008.253; published online 30 June 2008
J Gupta - One of the best experts on this subject based on the ideXlab platform.
-
pharmacological profiling of neuropeptides on rabbit Vaginal wall and Vaginal Artery smooth muscle in vitro
British Journal of Pharmacology, 2009Co-Authors: K L Aughton, K Hamiltonsmith, J Gupta, J S Morton, Christopher Peter Wayman, V M JacksonAbstract:Background and purpose: Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in peripheral arousal has been ignored. Vascular and non-vascular smooth muscle relaxation in the vagina is important for female sexual arousal. To date, in vitro studies have focused on Vaginal strips with no studies on Vaginal arteries. The aim of this study was to compare the effects of sexual hypothalamic neuropeptides on rabbit Vaginal wall strips and arteries. Experimental approach: Tissue bath and wire myography techniques were used to measure isometric tension from strips and arteries, respectively. Key results: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) relaxed both preparations, effects that were only antagonized by the VIP/PACAP antagonist VIP6–28 (10 nM) and the PAC1 antagonist PACAP 6–38 (1 μM). The melanocortin agonist α-melanocortin-stimulating hormone (1 μM), but not bremelanotide (1 μM), also relaxed both preparations. Oxytocin and vasopressin contracted Vaginal preparations, which could be antagonized by the V1A antagonist SR 49059. Neuropeptide Y (NPY) and the NPY Y1 agonist Leu31, Pro34 NPY only contracted arteries, which was antagonized by the NPY Y1 receptor antagonist BIBP 3226. Melanin-concentrating hormone (MCH; 1 μM) contracted arteries. Conclusion and implications: Hypothalamic neuropeptides can exert contractile and relaxant effects on Vaginal strips and arteries. NPY Y1, V1A, MCH1 antagonists as well as VIP/PAC1 agonists may have therapeutic potential in both central and peripheral female sexual arousal. Differences in effect of neuropeptides between preparations raise the question of which preparation is important for female sexual arousal. British Journal of Pharmacology (2008) 155, 236–243; doi:10.1038/bjp.2008.253; published online 30 June 2008
